Although the neoplastic significance of the chromosome changes widespread in Hodgkin's disease (HD) remains obscure, a distinct cytogenetic picture has emerged combining aneuploidy with structural rearrangements clustered at certain breakpoints. Notably absent are the recurrent chromosome translocations which distinguish other hematopoietic neoplasms and serve as clues to underlying oncogene alterations. The paucity of neoplastic cells in HD biopsies hinders detailed chromosome analysis. As an alternative, we investigated a panel of well characterized cell lines by classical and molecular cytogenetics, using single-gene and subtelomeric probes, including three autologous HD examples (HDLM-1/2/3) analyzed by 'spectral karyotyping' -the first complete HD karyotype to be documented. Although complex, most rearrangements in HDLM cells arose in vivo and included few rare but many typical HD breakpoints, notably at the r(ibosomal)DNA regions. Two types of genomic rearrangement involving DNA repeats were conspicuous: insertion and genomic amplification/coamplification of rDNA -the first genomic rDNA rearrangements to be reported in a tumor cell, and the first example of multiple 'jumping translocations' (JT). Of four subtelomeric microsatellite repeats tested in HDLM cells, three exhibited interstitial sites at JT, of which two (at 5qter and 9pter) were respectively associated with deletion of the 5q31-32 myeloid region, and coamplification of a recently described HD-recurrent amplicon at 9p2 together with transcriptionally silent rDNA. Altogether, three out of four HD cell lines carried interstitial 9p subtelomeres and rDNA rearrangements. Taken together, these data suggest tumorigenic rearrangements may be facilitated by 'hitchhiking' along with mobile DNA repeat sequences which may target gene rearrangement at 9p in HD. Southern analysis of parallel rearrangements within rDNA intergenic spacers in HDLM cells highlighted several at, or near, retroposons. As well as validating HD cell lines as cytogenetic models, and resources for identifying genes rearranged in HD, our findings warrant further investigation of the roles of DNA repeat sequences, notably subtelomeric microsatellites, rDNA spacer sequences and retroposons as facilitators and markers of tumor-gene rearrangement.
Introduction
Although the occurrence of multiple chromosome alterations in Hodgkin's disease (HD) was among the first recorded in a specific tumor, 1 a distinct cytogenetic picture has only recently emerged for this, nevertheless, common lymphoma. Accordingly, it seems that HD is characterized by aneuploidy and complex structural rearrangements clustered at several breakpoints. [2] [3] [4] Unlike other major hematopoietic neoplasms, consistent translocations dedicated to oncogene fusion are unknown in HD, their non-ascertainment traditionally ascribed to a constellation of technical problems. These include the shortage in biopsies of Hodgkin/Reed-Sternberg (H-RS) cells, posited as the karyotypically abnormal, pathognomonic clone in HD, 5, 6 which are outnumbered by reactive normal cells together with the, often excruciating, complexity of HD karyotypes. Nevertheless, given the steadily accumulating numbers of patients now described with clonal aberrations -a recent survey lists 177 such cases 4 -it seems increasingly likely that cytogenetic mechanisms other than classical oncogene-translocations might play a significant role in the pathogenesis of HD.
Until recently, the search for the normal counterpart of H-RS cells had proved equally fruitless; hence, the agonizing want of any consensus whether precursor outgrowth is monoclonal, 7 polyclonal 8 or both. 9 Immunogenetic studies performed on single H-RS cells now seem to implicate as progenitors B cells in which immunoglobulin expression was crippled by mutation during the germinal center reaction but which somehow evade apoptosis (reviewed in Ref. 10 ). The most recent data indicate a T cell origin is also possible, at least among a minority of cases. 11 HD cell lines, however, are about as likely to display B cell as T cell immunoprofiles. HD cell lines and microdissected H-RS cells have now been shown to display similar, although distinctive, gene expression profiles. 12 In view of the opportunities afforded for detailed investigation, suitable cell lines might be deemed a resource particularly advantageous for cytogenetic studies in HD, as in other intractable malignancies, eg. neuroblastoma. Until the recent advent of 24-color fluorescence in situ hybridization (FISH) imaging systems (reviewed in Ref. 13 ), such as 'spectral karyotyping' (SKY), 14 the need for piecemeal reconstruction of complex HD karyotypes from multiple FISH images hampered their documentation and the contingent ascertainment of novel changes therein, particularly in a tumor reputedly associated with genetic instability. 4 The present study exploited the twin resources of HD cell lines and SKY to address the following tasks: (1) documenting a pathognomonically complex HD karyotype; (2) ascertaining the significance of changes therein; and (3) identifying the most conspicuous cytogenetic changes and their candidate molecular targets.
Materials and methods

Cells and culture
The autologous (sister) cell lines designated HDLM-1/2/3 were independently established in 1982 from the pleural effusion of a 74-year-old male patient with stage IV nodular sclerosing disease without record of previous treatment 15 and have been extensively characterized as HD-analogous. [16] [17] [18] [19] [20] [21] [22] [23] [24] Cell culture conditions and the provenance, references, cellular origin and characterization of the remaining cell lines used in this study are given in Ref. 25 .
Cytogenetics
Standard cytogenetic harvesting, slide preparation, argyrophilic (ammoniacal silver) nuclear organizer region (AgNOR) staining, trypsin G-banding (GTG) and non-isotopic chromosomal in situ suppression hybridization were performed throughout. Chromosome painting was carried out according to manufacturers' protocols using probes labeled with the following: biotin or fluorescein isothianate (FITC) (Cambio, Cambridge, UK; or AGS, Heidelberg, Germany); Spectrum Orange or Spectrum Green (Vysis, Stuttgart, Germany); and digoxigenin (Roche Molecular Biochemicals, Mannheim, Germany).
The following subtelomeric probes were also tested: 5pter, 5qter (Oncor-Appligene, Heidelberg, Germany); and 1pter, 9pter (Vysis). Chromosome band assignments were checked using the following single locus probes (suppliers/donors): chr. 1 ␣-sat(ellite), chr. 2 ␣-sat, the consensus AML deletion region at 5q31, MYC at 8q24, chr. 9 ␤-sat at 9q12, ABL at 9q34, MLL at 11q23, chr. 13/21 ␣-sat, RB1 at 13q14.2, acrocentric chr. ␤-sat at p12 (of chr. 13, 14, 15, 21 and 22), chr. 14/22 ␣-sat, chr. 15 ␣-sat, PML at 15q22, MYH11 at 16p13, RARA at 17q21, chr. 17 ␣-sat, chr. 19q13.1, D22S75 at 22q11, BCR at 22q11, D22S39 at 22q13 (Oncor); ALK at 2p23, chr. D5S23 at 5q15.2, CSF1R at 5q32 (Vysis); pBE15H3 at 1p36 (E Fleckenstein, DSMZ); pNB101 for MYCN at 2p23 (R Corvi, German Cancer Research Center (DKF2), Heidelberg, Germany); Cos B5-2 for BCL6/LAZ3 at 3q27 (T Miki, Tokyo Medical and Dental University, Tokyo, Japan); P1.164 for ETO at 8q22 and CO664 for AML1 at 21q22 (A Hagemeijer, Center for Human Genetics, Leuven, Belgium); Cos-6.31/6.7 for BCL1 at 11q13 (S Brookes, Imperial Cancer Research Fund (ICRF), London, UK); Cos 148B6 and 179A6 for ETV6 at 12p13 (P Marynen, Center for Human Genetics, Leuven, Belgium); NNX3 at 19q12 (F Van Leuven, Center for Human Genetics, Leuven, Belgium); Cos 50B11 and 40D2 for MN1 at 22q12 (E Zwarthoff, Erasmus University, Rotterdam, The Netherlands); and probes spanning both coding (pA, pB) and spacer (pCb2b3, pDes, pDsh) regions of RRN (26, 27) as used for genomic analysis ( Figure 1 ). Single locus probes were labeled with digoxigenin-11-dUTP or biotin-14-dATP (Roche) by nick translation (Life Technologies, Karlsruhe, Germany), and 100-200 ng labeled probe dissolved in Hybrisol VI (Oncor) for hybridization (24 or 48 h) at 37°C in competition with a 50-
Figure 1
Ribosomal DNA probes used in this study. Location of probe inserts (shaded), spanning coding (black) and repeat units of the entire 44 kb human ribosomal repeat (RRN) cluster present in multiple copies on short-arm regions of chr. 13, 14, 15, 21, and 22 are shown. Regions A to D are defined by EcoRl sites (E). The absence of constitutive EcoRV sites from human rDNA was exploited in the search for genomic rearrangements involving RRN.
fold excess of Cot 1 DNA (Roche); excepting rDNA probes where competitor DNA was omitted.
To detect ␤-sat. DNA, primed in situ synthesis (PRINS) was performed using the following primers: 527, 5Ј-TCC-AAA-GCC-CAT-GTA-GGC-CGA-GCC-AAG-ACA-AGA-GT-3Ј; or  435, 5Ј-AGT-GCA-GAG-ATA-TGT-CAC-AAT-GCC-CC-3Ј (Eurogentec , Brussels, Belgium) to direct incorporation of digoxigenin-11-dUTP (Roche) using the procedure described in Ref. 28 .
Comparative reverse painting was performed to detect gross genomic imbalances, substituting for comparative genomic hybridization (CGH), and was based on the methods of Kallioniemi et al 29 and Joos et al. 30 Briefly, 200 ng DNA from each of HDLM-2 or KM-H2 and TMM (normal control) cell lines, contrastingly labeled by nick translation with Spectrum Red-dUTP and digoxigenin-11-dUTP, respectively, were cohybridized with 50-fold excess of Cot-1 DNA on to metaphases from the TMM cell line which has a normal karyotype. 25 Preparations were counterstained with 4Ј 6-diamidino-2-phenylindole (DAPI) and/or propidium iodide (PI) in Vectashield antifade medium (Camon, Wiesbaden, Germany). Probe signals were detected using anti-digoxigenin-FITC (Oncor) or avidin-Texas-Red (AGS) and viewed microscopically using bandpass filters (AHF Analysentechnik, Tuebingen, Germany). FISH images were recorded photographically (Kodak Ektachrome 400) or with a CCD camera configured to an image analysis system (Vysis).
Spectral karyotyping (SKY)
Spectral karyotyping analysis was performed as previously described.
14 Briefly, chromosome-specific libraries generated by PCR from flow-sorted human chromosomes were directly labeled with nucleotides conjugated to five different dyes (FITC, Rhodamine, Texas Red, Cy5 and Cy5.5). All 24 chromosome libraries were pooled to allow simultaneous hybridization to metaphases. After washing, the slides were counterstained with DAPI. The different spectra were distinguished using the SD200 spectral bio-imaging system (Applied Spectral Imaging, Migdal Ha'emeg, Israel) enabling measurement of full visible-light spectra at each pixel of the image with a Sagnac interferometer. A classification algorithm was used to discriminate between different spectra comprising the image and to assign pseudocolors to all the pixels with similar spectral characteristics: original and processed images are shown side by side in Figure 2f . The DAPI image was captured separately and inverted to give a G-banding pattern.
The chromosomes were then sorted automatically into a karyotype table.
Genomic analysis of rDNA rearrangements
The location of the probes used to detect genomic rearrangements is shown in Figure 1 . We confirmed by pulsed-field electrophoresis the absence of constitutive EcoRV sites reported in human rDNA. 31 Southern analysis of DNA samples restricted with this and other enzymes was used to detect rearrangements of rDNA. Thus, 10 g high molecular weight DNA from each cell line was incubated with 100 units restriction enzyme for 8 h at 37°C and ethanol-precipitated, the resultant pellets redissolved in 10 l H 2 O before loading on to a 1% agarose gel. Size-separated fragments were transferred on to a nitrocellulose membrane and fixed by heating (30 min at 120°C). Membranes were incubated with probes labeled with digoxigenin-11-dUTP using a random priming kit (Roche).
Results
The complex karyotypic structure of HDLM cells is depicted in the GTG and SKY images in (Figure 2a and b) , respectively. In the absence of any diagnostic karyotype, the presence of rearrangements common to two or more autologs was taken to indicate their origin in vivo, allowing reconstruction of the primary patient karyotype. The consensus karyotypes of HDLM-1/2/3 are listed in Table 1 according to ISCN. 32 Bihomological rearrangements of chr(omosomes) 2, 3, 6, 9, 14, 15, and 19 were distinguished textually by the suffices, 'a' or 'b'. Data describing HSR regions and rearrangements at, or close to, rDNA breakpoints in cell lines where rDNA was investigated molecularly are summarized in Table 2 . Non-HD cell lines were selected to include examples with acrocentric chromosome short arm (ASA) changes leading to their overrepresentation among controls. The modal chromosome numbers of HDLM-1/2/3 were 36 (major clone) and 37, the lowest stable counts recorded by us in more than 400 human tumor cell lines.
HDLM cells posed one of the severest challenges hitherto encountered by any 24-color FISH method in documenting a complex karyotype. Despite the complexity, close agreement prevailed between the results of conventional analysis (augmented by FISH) and SKY. In both cases, the most complex rearrangements required additional investigation with single-locus or subtelomere probes.
Origin and stability of rearrangements in HDLM cells
Cross-contamination is a major drawback to working with cell lines, 33 particularly in HD which lacks external identifiers in the form of recurrent translocations. The availability of three sister cell lines (unique among HD models) permits authentication based on convergent karyotypes and DNA profiles. The minimum set of karyotypic changes occurring in vivo may be identified on the same basis. Comparative representation of normal and marker chromosomes in HDLM cell lines (Table 1 ) reveals a remarkably high degree of conservation: of the 24 markers listed for HDLM-2, 21 (88%) and 20 (83%) are present in HDLM-1 and −3, respectively, with 19 (79%) common to all three. Thus, despite extreme complexity, only Leukemia minor karyotypic differences distinguish the three sisters, simultaneously implying an origin in vivo and stability in vitro for the shared rearrangements. The dominant clone in HDLM-2, which was selected for the most detailed study, maintained a stable karyotype over several hundred population doublings.
Breakpoints in HDLM cells
Rearrangements at the following 48/52 breakpoints detected in HDLM-2 cells were present in two or more HDLM cell lines, indicating origin in vivo: 1p21, 1q11, 2p13, 2q37, 3q21, 3q26, 3q27-28, 4q24-25, 4q31, 5p11, 5p15.3, 5q11, 5q13, 5q31, 5q34, 5q35, 6q15-16, 6q22-24, 7p14, 8q21-22, 8q24, 9pter, 9p11, 9p21, 9p24, 11q13, 12p12, 12q24.32, 13p12, 13q13-14, 14p12, 14q21, 14q31, 15p12, 15q12, 15q21, 15q25, 16p11, 16p13.2, 17cen, 17q25, 18p11, 18q23, 19p13, 19q12-13, 21q11.2, 22p12, 22q13. Some breakpoints were hotspots; excluding reiterations, three or more rearrangements occurred at the following breakpoints (× frequencies):
The resemblance of the breakpoint array in HDLM cells to that reported clinically, was assessed by comparison to the relative frequencies of different breakpoints in HD patients with clonal aberrations reported in Refs 4, 34-44. Thresholds of 'low' and 'high' frequency HD-breakpoint classes were arbitrarily set to yield approximately equal likelihoods in a pilot study. Accordingly, HD-negative breakpoints (reported in 0-4 HD patients, mean = 1.6) comprised: Xp1, Xp2, Xp10, Xq1, Xq10, 1p10, 2p10, 2q1, 2q10, 2q2, 3p10, 3q10, 4p10, 4q1, 4q10, 5p10, 5q10, 6p1, 6p2, 6p10, 6q10, 7q10, 8p1, 8q10, 9q10, 10p1, 10p10, 10q1, 10q10, 11p10, 11q10, 12p10, 12q10, 13p10, 13q10, 14p10, 14q10, 15p10, 15q2, 15q10, 16p10, 16q1, 16q10, 17p10, 17q1, 18p10, 18q1, 18q10, 19p10, 19q10, 20p1, 20p10, 20q10, 21p10, 21q1, 21q2, 22p10; and HD-positive (present in 14-28 HD patients, mean = 19.0) comprised: 1p3, 3q2, 4q2, 4q3, 5q1, 6q1, 6q2, 7q2, 7q3, 11q2, 12p1, 12q2, 13p1, 14p1, 14q3, 15p1. (Centromeric p10/q10 were treated separately from remaining p1/q1 breakpoints to distinguish isochromosomes from ASA with putative rDNA involvement.) Concordance to the cytogenetic picture reported for HD was derived by subtracting numbers of HD negative from positive breakpoints present in each cell line. As anticipated, concordance among the 13 highly rearranged control cell lines (BE-13, DEL, GRANTA-519, HEL, KARPAS-45, MEG-01, MEGAL, SR-786, SU-DHL1, SUP-B2, TANOUE, WSU-NHL, YT) approximated zero (mean 0.23, range +2 to −2), indicating the level of the stochastic background. HDLM cells (with 12/16 positive, but only 3/57 negative) breakpoints yielded a net concordance score of 9 -more than four times greater than any control. It was noteworthy that 3/16 HD-positive classes (13p1, 14p1, and 15p1) represent ASA breakpoints at which the only coding sequences known are for rDNA, and that all three are rearranged in HDLM cells. This prompted additional investigation into the nature of the cytogenetic changes involved and their possible genomic basis.
Genomic deletion and amplification
Ignoring ASA regions, the following chromosomal regions of HDLM-2 cells were aneusomic as follows; nullisomic: 5p11- (green) and 5qtel (D5S2907) (red). Note interstitial signals of 5pter/qter in der(19a) (lowest arrow) and ins(4;5) (middle arrow), and of 5pter in der(Y) (arrow, above left). These patterns coincide with jumping translocations (JT) present at these loci. D5S2907 cross-hybridizes to acrocentric chromosome short-arm regions (arrowheads) indicating homology to sequences at, or close to, native rDNA. FISH with subtelomeric probes for 9pter (green) in HDLM-2 (e) and KM-H2 (f). Note interstitial signals along der(19b) in HDLM-2, associated with coamplification (arrowhead) and absent or weakened native sites in KM-H2 (arrowhead). (g) Amplification and co-amplification of rDNA: FISH using an rDNA probe (Cb2b3) shows intense signals on ders(3b) and (9b) (arrows) and striated signals on der(19b) (arrowhead); and the image in(h) shows how striation is repeated after FISH with a painting probe for chr. 19 (red) indicating its co-amplification (arrowhead) together with rDNA in der(19b), identified from its short-arm including material from 17q (green). Note the similar pattern of striation shown by chr. 9pter subtelomeres in der(19b) in (e). (j) Transcriptional heterogeneity: AgNOR (argyrophilic) staining to detect actively transcribing rDNA reveals active rDNA amplification in ders (3b) and (9b) (arrows), while der(19b) is transcriptionally silent. (k) Structural heterogeneity: PRINS detection of ␤-sat. DNA (green) in chromosomes counterstained with DAPI and Pl again shows striation in der(19b) (arrowhead), while the AgNOR-positive regions of der(3b) and der(9b) (Pl-positive/DAPl negative) yield no signal (arrows). Note ␤-sat. DNA sites corresponding to rDNA regions and to additional native sites at 1q12. Green/red fluoresent probes were either directly labeled with F-12-dUTP/spectrum red-dUTP, or haptenized with digoxigenin/biotin and detected using anti-digoxigenin-FITC/avidin-Texas-Red, respectively. Chromosomes were counterstained with DAP unless otherwise indicated. q11, 9pter→p22, 21pter→q11.2; monosomic: 1p11→1p21, 2q37→qter, 3q27-qter, 4q11→q24, 5pter→q11, 5q31→q32, 7pter→p14, 8pter→q21, 12q24.32→qter, 16p11→qter, 17q25→qter, 18pter→18p11.2, 20pter→qter, trisomic: 3q21-27, 5q32→35, 6q24→qter, 8q22→q24.3, 19pter→q12, 19q13→qter; tetrasomic; 9q31→qter, 12pter→p12; and heptasomic: 9pter→p2. Only 4/10 native ASA telomeric sites remained (Table 1) .
Major amplifications, detectible by comparative reverse painting in HDLM-2 and KM-H2 cells, were strongest among ASA, housing ␤-sat. DNA and rDNA, which bore brilliant monochromatic signals, whereas q12 regions of chr. 1 and 9, housing ␤-sat. DNA, were negative after hybridization with DNA from KM-H2 or, in the case of HDLM-2, yielded dim signals only (Figure 2c) . Thus, despite the quantitative limitations of the method, significant amplification of ASA sequences including rDNA was present in both HDLM-2 and KM-H2 cells.
Translocations and marker evolution in HDLM and other HD cell lines
Unbalanced rearrangements predominate among epithelial tumors, while balanced translocations more typify hematopoietic malignancies. 45 The products of only four reciprocal translocations are identifiable in HDLM, cells, some in cryptic form: t(2;8)(p13;q24.3) in der(2a) and der(8); t(3;6)(q27;q22) in der(3a) and der(6b); t(11;16)(q13;p16.2) in der(11) and der(13); and t(14;15)(q24;q13or23) in der(3a) and der(14a). None of the more obvious oncogene rearrangements associated with these, or neighboring, breakpoints were detected using the probes listed above including BCL6/LAZ3 at 3q27, C-MYC at 8q24, BCL1 at 11q13, ETV6/TEL at 12p13, and MYH11 at 16p13.
The karyotypic structure of HDLM cells was found to include an unprecedented number of 'jumping translocations' (JT), involving 15 sets of promiscuous breakpoints at: 2p13, 3q27, 4q24-25, 5pter, 5p11, 5qter, 6q24, 8q21-22, 13q13, 15q25, 17q10, 19q1, 21q1, 22q13, and at rDNA regions. Investigation using subtelomeric probes serendipidously revealed 5p/qter interstitial subtelomeres juxtaposed in ins(4;5) as well as the following rearrangements: 5pter with Yq11 in der(Y) and 1p3 in der(19a) where 5qter was, in turn, juxtaposed with 1q11 ( Figure 2d) . Interestingly, chr. 5 material present in der(19a) had sustained deletion of the 5q31-32 AML critical deletion region (data not shown). In most (22/25) metaphases, cross-hybridization signals from 5qter (D5S2907) were present at the short arms of some acrocentric chromoLeukemia somes (Figure 2d ). The systematic cross-hybridization of D5S2907 (but not of other subtelomeric probes) with rDNA regions was confirmed by the manufacturers (Dr JC Tunstall, Cytocell, Oxford, UK, personal communication) and might have arisen by homology between some 5q subtelomeric and ASA sequences. Of two remaining subtelomeric probes, tested, that for 1pter displayed no untoward rearrangement, while that for 9pter detected about four interstitial sites regularly distributed along the q-arm of der(19b) (Figure 2e ). Thus, cryptic interstitial rearrangement was exhibited by three out of four subtelomeres tested in HDLM cells. In view of these results, subtelomeric probes at 1p, 5q and 9p were also tested in three other HD cell lines (KM-H2, L-428, L-540). Interstitial sites for one probe, 9pter, were present in KM-H2 and L-428, but not in L-540. In KM-H2 all detectable 9pter sites were interstitial apart from a sporadic weak, possibly rearranged, site (Figure 2f ). In addition to classical JT which generate genomic imbalances, the occurrence of cryptic JT was inferred from breakpoint delineations, revealing the segregated ('reshuffled') products of putative balanced translocations, eg the centric and acentric fragments of chr. 2 sharing the 2p13 breakpoints present in the apparently unrelated markers, der(2b) and der(12), juxtaposed with 13q14 and 8q24, respectively. Despite the visually identical breakpoints, breakage at 2p13 had occurred independently in both homologs, rather than by duplication, as shown by the retention of heterozygosity on both arms of chr. 2 (at D2S44 and ApoB) in HDLM cells. 25 By following the trails of cryptic JT, it was possible to infer translocation pathways. Thus, in the case of the latter rearrangement at 2p13, the occurrence of t(8;2;13;22;14)(q24;p13;q13-14;q13;p12) was inferred, leading to the ASA region on chr. 14 -the identity of any further partners in this putative chain disguised by the anonymity of the residual 14pter→p11 segment. Figure 3 shows how a network, concentrated at promiscuous breakpoints -notably rDNA regions -could be constructed, linking 22/24 markers via the occurrence of duplications or conventional and 'jumping' translocations.
Multiple rearrangement of rDNA and ␤-sat. DNA in HDLM cells
Multiple cytogenetic rearrangements of rDNA are present in HDLM cells. These include nine ectopic rDNA rearrange- 
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Data describe cells used for Southern analysis. All, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CML, chronic myeloid leukemia; HD, Hodgkin's disease; HSR, homogeneously staining region; LCL, lymphoblastoid cell line; NHL, non-Hodgkin's lymphoma; NT, not tested; (*), derived from patient with multiple myeloma; (+) present in stemline; (+/−) present in sideline. Non-HD cell lines preselected to include rDNA changes.
ments, of which four may be insertions -given the bilateral removal of flanking ␤-sat. sequences. Both ectopic rearrangement of rDNA and Robertsonian translocations were found in HD cell lines, although only the latter were usually present in controls (preselected to exhibit ASA rearrangement) ( Table 2 ). Genomic amplification of rDNA shown by comparative reverse painting (Figure 2c ) was confirmed by hybridization with an rDNA plasmid probe, Cb2b3 (Figure 2g ) and was also apparent from the enhanced signals revealed by Southern analysis (data not shown). While amplicons in der(3b/9b) were intense and unbroken, that of der(19b) was striated, about four-fold. FISH with painting probes revealed identical parallel striations of material from chr. 19 (Figure 2h ), refined to 19q1?2, and from chr. 9 (data not shown), refined to 9p2 -given their collocation with signals from the 9pter interstitial subtelomeres (Figure 2e ). AgNOR staining (Figure 2j ) showed
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Interrelationships between HDLM marker chromosomes. that der(3b) and der(9b) bore similar large, active NORs, while the HSR dominating the long arm of der(19b) was negative implying transcriptional silence of the rDNA amplified therein (Figure 2g ). This pattern was reversed after PRINS, using primers specific for ␤-sat. DNA which revealed heavy staining of the der(19b) HSR with again four strong bands (matching rDNA, chr. 9p2 and chr. 19 signals), whereas the AgNORpositive HSR regions of der(3b) and der(9b) yielded no signal (Figure 2k ). Together, these results indicated amplification of incomplete and disparate ASA regions associated in both cases with chr. 9p2 and 19q1. As well as regions of chr. 9 and 19 present in der (3b), der(14b) and der(19b), additional breakpoints were juxtaposed with rDNA in some other markers: 9p11 in der(9a) and der(9b), 16p11 in der(13), 17q10 in dic(15;17), 18p11.2 in der(18), and 21q11.2 in der (22) .
Genomic rearrangement of rDNA in HDLM cells
The presence of multiple chromosome rearrangements of rDNA in HDLM cells prompted investigation, using a series of rDNA probes spanning spacer and coding sequences, to detect genomic alterations by restriction with EcoRV for which no sites are present inside the 44 kb rDNA repeat (Refs 31, 46; RAF MacLeod, unpublished). Figure 4a shows a 4.9 kb EcoRV fragment detected by the pCb2b3 spacer probe unique to HDLM cells among the panel of 26 cell lines tested. Densitometric comparison of the 4.9 kb band to a heterozygous single locus probe (pYNH24) suggested the copy number of the fragment lay in the range 2 to 8 per cell (Figure 4b) . Two additional RRN spacer rearrangements unique to HDLM cells were also detected: a 23 kb EcoRI fragment detected by the pDes probe ( Figure 4c) ; and a 5.7 kb Xbal fragment detected by the pDsh probe (Figure 4d) , both present at high copy number. As expected, additional high copy number constitutive Multiple genomic rearrangement of ribosomal DNA. Detection of non-polymorphic rearrangements in HDLM cells using rDNA spacer probes is shown: (a) a 4.9 kb EcoRV fragment detected by pCb2b3, shown by comparison with a unique sequence probe (pYNH24) in (b) to be present at about 2-to-8 copies per cell; (c) a 23 kb EcoRI fragment detected by pDes present at high copy number shown together with the constitutive 18.1 kb band; and (d) a 5.7 kb Xbal pDsh fragment also present at high copy number, shown together with the 1.6 kb constitutive band. The Southern hybridizations (shown in e and f) depict double digestion with EcoRV together with, HindIII (H) and Xbal (X), respectively. The weakness of the 3.3 kb Hindlll/EcoRV fragment (e) supports the orientation proposed in (g) implying de novo EcoRV sites immediately 5Ј of the b2 EcoRI (E) site and 3Ј of Cb6. Note the pair of stronger constitutive Hindlll fragments, one of which (1.6 kb) obscures a constituent part of the original fragment (e). This orientation was consistent with the 0.75 kb and 1.32 kb fragments generated by EcoRV/Xbal digestion. To reconcile the incompatibility of the restriction map with native sites, the occurrence of insertion, followed by low-level amplification, of a fragment comprising most of Cb2b3 into a distant EcoRV-rich milieu is proposed (h).
bands, of 18.1 kb and 1.6 kb were detected by pDes and pDsh, respectively, in all cell lines.
To refine the mapping of the 4.9 kb EcoRV band in relation to the rDNA C region, additional single and double digests were performed with endonucleases recognizing sites in this region (Figure 4e and f) . These showed the presence of a single Hindlll site but none of Sall or EcoRI inside the fragment. Digestion with EcoRV/Hindlll had split the 4.9 kb fragment into two bands: 3.3 kb and an intenser band of 1.6 kb (Figure 4e ) which, together with the presence of an Hindlll site in the Cb2b3 region 5Ј of B2 and 3Ј of Xbal, suggested one of its flanking EcoRV restriction sites lay immediately 5Ј of the Cb2 EcoRI site placing the other 3Ј of Cb6 (Figure 4g ). (Figure 4g and h) and EcoRl/Xbal each revealed a pair of bands of equal intensity at 0.75 kb and 1.32 kb, while digestion with Xbal/Hindlll again revealed the 1.32 kb band together with a weak 0.48 kb band, both patterns consistent with the orientation proposed in Figure 4g . Inspection of the sequence published for this region 46 failed to disclose any simple rearrangement capable of generating the observed result, so it was inferred that the 4.9 kb band probably arose by insertion within another region replete with EcoRV sites (Figure 4 h), possibly followed by low-level (up to 8-fold) amplification, ie reminiscent of the partial rDNA sequences present in der(19b) coamplicon.
Digestion with both EcoRV/Xbal
Discussion
Instability
Multiple structural and numerical rearrangements have been consistently reported in HD patients and cell lines. 4, 47 Although instability is sometimes assumed to be inherent in cytogenetically complex cell lines, the supporting evidence is scanty and vanishingly few controlled longitudinal studies have been reported. In fact, Tosi et al 48 observed cytogenetic stability in a highly rearranged AML cell line (GF-D8) studied by multiplex-FISH. The karyotypic stability of HDLM-1/2/3 in vitro is not unusual, therefore, and their close resemblance shows most shared rearrangements arose in vivo, perhaps under developmental control. Levels of rearrangement, like those of other HD cell lines (MacLeod et al, in preparation) , are the most extensive yet seen in hematopoietic cells. A clue to the conundrum of apparently gratuitous rearrangement in HD is supplied by the massively altered gene expression profiles in hematopoietic malignancies, 49 including HD. 50 And, rather than a mere side-effect as hitherto believed, aneuploidy has been recently reinstated as a cause of tumorigenesis, perhaps exceeding single-gene alterations in neoplastic importance. 51 A second notable feature of chromosome rearrangements in HDLM cells was inter-relatedness, as shown by the 'networking' of 22/24 markers present ( Figure 3 ) and reflecting the profusion of JT, only recorded as single instances hitherto, mainly in hematopoietic neoplasms. There specific oncogenes are targeted. 52, 53 possibly explaining the secondary chromosome instability in leukemia we have observed close to rearranged oncogenes. 54 We also found a stable, complex rearrangement -a four-way translocation and inversion -in a pre-B ALL cell line (REH) dedicated to non-reciprocal fusion of TEL with AML1, 55 supporting the inference that complex changes in HDLM cells, eg, the putative five-way t(8;2;13;22;14) might also be facilitatory. Several reports link JT with interstitial telomere sequences, 56, 57 whether random as suggested by Andreasson et al 58 or facilitatory as implied by the current report. Both (p/q) interstitial telomeres of chr. 5 were associated with JT ( Figure 2d ) and the homology of one (5 q) to sequences present at ASA hints at a possible common target for instability. Chr. 5 p/q subtelomeres were also involved in a complex deletion of chr. 5 q material present in der(19a) leading to loss of the 5q31-32 critical AML regionrare in lymphoid cells. The third interstitial subtelomere, 9pter, was directly involved with rDNA, this time in co-amplifying sequences close by at 9p2 (Figure 2e, g-k) , recently shown to be a recurrent feature in HD where JAK2 (at 9p24) has been proposed as an intended target. 59 Amplification of JAK2 has now been confirmed in HDLM cells (Dr Stefan Joos, DKFZ, Heidelberg, Germany, personal communication to RAFM) which, as shown here, emerges as the first model for oncogenic change in HD. That three out of four subtelomeric microsatellite probes tested exhibited interstitial rearrangement in HDLM cells suggests high mobility and that more such sites may be present. Our findings raise the possibility that microsatellite instability (MI) now reported in HD 60 might promote subtelomere rearrangement and JT formation.
Possible roles for rDNA changes
ASA rearrangements together comprise by far the most numerous breakpoints reported in HD, [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] in particular those anaLeukemia lyzed before treatment, 40 implying a spontaneous origin rather than via therapeutic induction. Ectopic rDNA has been noted previously in the L-540 HD cell line 61 which, as reported in this study (Table 2) , may be a more general feature of HD cell lines. Given their clinical frequency, the presence of rDNA changes, including amplification, in near-identical form in all three of HDLM-1/2/3 and in KM-H2 cells suggests a role in tumorigenesis. ASA are also the only HD breakpoints at which the identities of target genes may be readily inferred, as the rDNA repeats are the only genes located there. 62, 63 Here, we show that rDNA is rearranged genomically in HDLM cells, as suggested by cytogenetic analysis, and amplified in both HDLM and KM-H2 cells. Like interstitial subtelomeres, rDNA/ASA rearrangements in HD cell lines might reflect a DNA processing defect occurring either passively, or as a means to facilitate gene rearrangement.
Structure is sometimes a clue to function. The structure of rDNA rearrangements in HDLM cells shared three salient features: (1) loss of flanking sequences, eg ␤-sat. DNA (Figure 2k (Figure 3) , repeatedly in the case of material from chr. 9p2 and 19q12-13. Insertion and amplification were also discernible at the DNA level. Although gene amplification occurs during development of insects and amphibia -and, intriguingly, also preceded by insertion among ciliate protozoa 64 -reports in human cells are restricted to metabolic genes undergoing selection, or to oncogenes, the more likely alternative here. Interestingly, coamplification of EGFR and rDNA has been reported in a hepatoma cell line, 65 pointing to a 'hitchhiking' mechanism, perhaps exploiting the genomic mobility of rDNA, 66 as implied by its complex structure within der(19b). A similar mechanism targeting amplification of the 9p2 JAK2 region (and possibly chr 19q12-13) may have operated in HDLM precursors.
In contrast to ASA (p11-p13) breakpoints, there is no excess of centromeric (p10/q10) rearrangements in HD [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] to indicate targeting any of the several families of resident DNA repeats, notably ␣-sat. DNA. Thus, sequence redundancy would, in itself, appear to be insufficient to provoke instability in HD, leaving microsatellites as a more plausible target, consistent with the report of Mark et al, 60 who observed MI in H-RS cells.
A second clue to the nature of instability affecting HDLM cells is the ubiquity of insertional rearrangements of rDNA where a variety of potential retroposon effectors are close at hand. The Cb2b3 region rearranged in HDLM cells includes two types of multifunctional retroposon sequence: Alu elements (also known to act as transcriptional regulators) and a processed pseudogene of CDC27HS, the human homolog of a yeast mitotic checkpoint inhibitor. 46, 67 Restriction mapping implies insertion as the most parsimonious explanation for the origin of this fragment (Figure 4e-h ) whose 'cut, copy and paste' features are reminiscent of rDNA present in der(19b) (Figure 2e, g-k) . Retroposons may facilitate tumor cell proliferation 68 and chromosome instability. 69 In addition, Alu sequences have been identified at BRCA1 breakpoints in breast/ovarian cancer families. 70 In addition to silent (AgNOR-negative) rDNA discussed above, HDLM and KM-H2 cells amplify AgNOR-positive rDNA present in markers. A positive association between AgNOR activity and tumor stage in HD has been reported. 71, 72 Regulation of rDNA transcription involves several tumorigenic pathways mediated through key molecules, including RB1 and TP53 74 for which a binding site is present downstream of Cb2b3. 46 
Lineage
Despite initial controversy, 75 it is now accepted that most cases of HD originate from B cells. 10 HDLM, in common with some other HD cell lines, however, display T cell immunoprofiles leaving open the possibility of their adventitious origin from reactive T cells. 47 However, recent studies show that HD may indeed sometimes derive from T cells. 11, 12 In addition, the restriction of chromosome changes in HD to the neoplastic H-RS clone 76 is at variance with a 'bystander' origin for the complex changes in HDLM cells which, unlike T cell lines, are devoid of both TCF1 and GATA3 expression. 77 Thus, in HD, as with certain other tumors, 78 ,79 rarer subtypes may be over-represented among cell lines, perhaps because their mutation-spectra include alterations which favor growth in vitro. 80 
A model and a resource
Although HD is the most common lymphoma, few cell lines have been established. Of the dozen listed by Drexler, 81 only a minority pass muster. Some examples (including DEV, HD-70 and L1236) are restricted to private distribution, while the origins of others (including HD-MyZ, HKB-1 and SBH-1) are dubious. 47 Of the remainder, AG-F and CO are cross-contaminated in both cases by the T cell ALL cell line, CCRF-CEM. 82 Hence, the characterization of the shortlisted HDLM-1/2/3, KM-H2, L-428 and L-540 assumes added importance. By portraying the cytogenetic picture of HD, the claim of HDLM cells to act as in vitro models is strengthened.
Although not obviously matching known lists of spontaneous or induced fragile sites, 83 it remains unclear whether HD breakpoints generally represent chromosome fragility or specific gene rearrangements, or the facilitation by the former of the latter. Some HD breakpoints distinctly resemble those found in other lymphomas (eg 6q2) and may target the same genes. Other breakpoints found in the HDLM cell lines at which genes with a more restricted distribution have been proposed include the following: 9p23-24, JAK2 (59); 12q24, restin (84) and BCL7A (85); 11q13, NFKB3 (86); 4q25, NFKB2 (87) and 19q12, NNX3. 88 Additional breakpoints of interest include 7p14 (TCRG) as well as those juxtaposed with rDNA and, hence, possible targets for facilitatory rearrangement.
Summary and conclusions
By exploiting the twin resources of HDLM cells and SKY, we have described the first complete HD karyotype. Several novel features were thus revealed, including multiple jumping translocations involving interstitial subtelomeres and ectopic rDNA. The latter flank an amplicon at 9p2 recently shown to be recurrent in HD and the presence of 9p subtelomeres in 3/4 HD cell lines tested may well indicate a more general involvement in HD. We also identify a possible target for instability at acrocentric chromosome regions, the most prolific breakpoints in HD, in the form of retroposon sequences present inside the rDNA spacer region. To explain these findings, we propose that oncogene amplification is facilitated by a 'hitchhiking' mechanism exploiting inherent instability of specific types of repetitive DNA. In view of these results, we propose that future studies of HD should determine: (1) the incidence of JT or interstitial subtelomeres; and (2) whether these or other types of repeat DNA might betray oncogene involvement by recurrent juxtaposition with specific genes.
